Eric Siu

1.1k total citations
23 papers, 813 citations indexed

About

Eric Siu is a scholar working on Molecular Biology, Economics and Econometrics and Organic Chemistry. According to data from OpenAlex, Eric Siu has authored 23 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Economics and Econometrics and 4 papers in Organic Chemistry. Recurrent topics in Eric Siu's work include Nicotinic Acetylcholine Receptors Study (8 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Synthesis and Biological Evaluation (4 papers). Eric Siu is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (8 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Synthesis and Biological Evaluation (4 papers). Eric Siu collaborates with scholars based in Canada, United States and Australia. Eric Siu's co-authors include Rachel F. Tyndale, Harold Reiter, Dieter B. Wildenauer, Kelly Dore, Clyde Matava, M. Dylan Bould, Jonathan Sherbino, Geoff Norman, Lionel Christiaen and Florian Razy‐Krajka and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and PLoS Biology.

In The Last Decade

Eric Siu

21 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Siu Canada 15 321 228 151 149 101 23 813
Jack A. Grebb United States 13 323 1.0× 594 2.6× 280 1.9× 171 1.1× 21 0.2× 19 1.5k
Patrick Sullivan United States 12 185 0.6× 95 0.4× 86 0.6× 234 1.6× 18 0.2× 42 674
Martha L. Elks United States 18 343 1.1× 200 0.9× 95 0.6× 206 1.4× 107 1.1× 43 861
Jennifer G. Duncan United States 17 480 1.5× 108 0.5× 57 0.4× 303 2.0× 32 0.3× 39 1.6k
Gregory D. Salinas United States 15 181 0.6× 128 0.6× 97 0.6× 93 0.6× 4 0.0× 48 782
Sarah Burgess Canada 13 134 0.4× 39 0.2× 64 0.4× 83 0.6× 23 0.2× 32 601
Jan Matthes Germany 18 551 1.7× 127 0.6× 200 1.3× 89 0.6× 4 0.0× 67 1.1k
Jay Moskowitz United States 14 86 0.3× 247 1.1× 40 0.3× 56 0.4× 40 0.4× 26 647
Jennifer Johnston Australia 16 66 0.2× 151 0.7× 58 0.4× 43 0.3× 14 0.1× 42 904
Brian S. Barnett United States 13 143 0.4× 65 0.3× 71 0.5× 9 0.1× 23 0.2× 91 752

Countries citing papers authored by Eric Siu

Since Specialization
Citations

This map shows the geographic impact of Eric Siu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Siu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Siu more than expected).

Fields of papers citing papers by Eric Siu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Siu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Siu. The network helps show where Eric Siu may publish in the future.

Co-authorship network of co-authors of Eric Siu

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Siu. A scholar is included among the top collaborators of Eric Siu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Siu. Eric Siu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Siu, Eric, et al.. (2019). An ever-evolving landscape: an update on the rapidly changing regulation and reimbursement of biosimilars in Canada. Generics and Biosimilars Initiative Journal. 8(3). 107–118. 4 indexed citations
2.
3.
Siu, Eric, et al.. (2016). Current state of subsequent entry biologics (biosimilars) in Canada: a view from regulatory, reimbursement, clinician, and patient perspectives. Generics and Biosimilars Initiative Journal. 5(3). 105–113. 3 indexed citations
4.
Siu, Eric, et al.. (2015). Canadian Public Reimbursement of Subsequent Entry Biologics (Sebs) / Biosimilars. Value in Health. 18(3). A168–A169. 1 indexed citations
5.
Siu, Eric, et al.. (2015). Free Flap Reconstruction Experience and Outcomes at a Low‐Volume Institution over 20 Years. Otolaryngology. 152(5). 832–837. 27 indexed citations
6.
Chan, Kelvin, Eric Siu, Lee Mozessohn, & Matthew C. Cheung. (2013). Publication Patterns of Cancer Cost-Effectiveness Studies Presented at Major Conferences. Current Oncology. 20(6). 319–325. 5 indexed citations
7.
Wang, Wei, et al.. (2013). NK4 Antagonizes Tbx1/10 to Promote Cardiac versus Pharyngeal Muscle Fate in the Ascidian Second Heart Field. PLoS Biology. 11(12). e1001725–e1001725. 59 indexed citations
8.
Matava, Clyde, et al.. (2013). eLearning among Canadian anesthesia residents: a survey of podcast use and content needs. BMC Medical Education. 13(1). 59–59. 69 indexed citations
9.
AlSharari, Shakir D., Eric Siu, Rachel F. Tyndale, & M. Imad Damaj. (2013). Pharmacokinetic and Pharmacodynamics Studies of Nicotine After Oral Administration in Mice: Effects of Methoxsalen, a CYP2A5/6 Inhibitor. Nicotine & Tobacco Research. 16(1). 18–25. 24 indexed citations
10.
Miyashita, Leo, et al.. (2013). i-me TOUCH. 1–1.
11.
Siu, Eric, Michael A. Campitelli, & Jeffrey C. Kwong. (2012). Physical Activity and Influenza-Coded Outpatient Visits, a Population-Based Cohort Study. PLoS ONE. 7(6). e39518–e39518. 12 indexed citations
12.
Grieder, Taryn E., Laurie H. L. Sellings, Héctor Vargas-Pérez, et al.. (2009). Dopaminergic Signaling Mediates the Motivational Response Underlying the Opponent Process to Chronic but Not Acute Nicotine. Neuropsychopharmacology. 35(4). 943–954. 29 indexed citations
13.
Siu, Eric & Harold Reiter. (2009). Overview: what’s worked and what hasn’t as a guide towards predictive admissions tool development. Advances in Health Sciences Education. 14(5). 759–775. 127 indexed citations
14.
Dore, Kelly, Harold Reiter, Kevin W. Eva, et al.. (2009). Extending the Interview to All Medical School Candidates—Computer-Based Multiple Sample Evaluation of Noncognitive Skills (CMSENS). Academic Medicine. 84(Supplement). S9–S12. 34 indexed citations
15.
Shram, Megan J., Eric Siu, Zhaoxia Li, Rachel F. Tyndale, & Anh D. Lê. (2008). Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats. Psychopharmacology. 198(2). 181–190. 51 indexed citations
16.
Siu, Eric & Rachel F. Tyndale. (2007). Selegiline Is a Mechanism-Based Inactivator of CYP2A6 Inhibiting Nicotine Metabolism in Humans and Mice. Journal of Pharmacology and Experimental Therapeutics. 324(3). 992–999. 37 indexed citations
17.
Siu, Eric & Rachel F. Tyndale. (2007). Non-Nicotinic Therapies for Smoking Cessation. The Annual Review of Pharmacology and Toxicology. 47(1). 541–564. 58 indexed citations
18.
Damaj, M. Imad, Eric Siu, Edward M. Sellers, Rachel F. Tyndale, & Billy R. Martin. (2006). Inhibition of Nicotine Metabolism by Methoxysalen: Pharmacokinetic and Pharmacological Studies in Mice. Journal of Pharmacology and Experimental Therapeutics. 320(1). 250–257. 31 indexed citations
19.
Siu, Eric & Rachel F. Tyndale. (2006). Characterization and Comparison of Nicotine and Cotinine Metabolism in Vitro and in Vivo in DBA/2 and C57BL/6 Mice. Molecular Pharmacology. 71(3). 826–834. 80 indexed citations
20.
Siu, Eric, Dieter B. Wildenauer, & Rachel F. Tyndale. (2006). Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5. Psychopharmacology. 184(3-4). 401–408. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jack A. Grebb Breakdown of academic impact, for papers by Patrick Sullivan Breakdown of academic impact, for papers by Martha L. Elks Breakdown of academic impact, for papers by Jennifer G. Duncan Breakdown of academic impact, for papers by Gregory D. Salinas Breakdown of academic impact, for papers by Sarah Burgess Breakdown of academic impact, for papers by Jan Matthes Breakdown of academic impact, for papers by Jay Moskowitz Breakdown of academic impact, for papers by Jennifer Johnston Breakdown of academic impact, for papers by Brian S. Barnett
Rankless by CCL
2026